Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TtbioROCO:6493 -5.15%60 Forward Dividend Yield % is 0.39% as of Jul. 15, 2026. GuruFocus rates ROCO:6493 with a GF Score™ of 60/100 and a GF Value™ of NT$19.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Ttbio ranks worse than 91.72% on this metric.
As of today (2026-07-15), the Forward Annual Dividend Yield of Ttbio is 0.39%.
As of today (2026-07-15), the Trailing Annual Dividend Yield of Ttbio is 0.39%.
ROCO:6493's Forward Dividend Yield % is ranked worse than 91.72% of 314
companies
in the Medical Devices & Instruments industry
Industry Median: 2.085
vs ROCO:6493: 0.39
During the past 12 months, Ttbio's average Dividends Per Share Growth Rate was -30.80% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -25.40% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Ttbio was -25.40% per year. The lowest was -30.70% per year. And the median was -29.00% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
ROCO:6493 vs ISRG, BDX, MDLN: Forward Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Ttbio's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ttbio Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ttbio's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Ttbio's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Ttbio Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
TWD 0.200083
2025-07-28
2025-07-29
2025-08-15
Cash Dividend
annually
TWD:TWD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Ttbio's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.200083
/
48.85
=
0.41 %
Current Share Price is NT$48.85. Ttbio's Dividends per Share for the forward twelve months is calculated as NT$0.200083 * 1 = NT$0.200083.
Ttbio's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.200083
/
48.85
=
0.41 %
Current Share Price is NT$48.85. Ttbio's Dividends per Share for the trailing twelve months (TTM) ended in Today is NT$0.200083.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 0.39% mean?
Ttbio (ROCO:6493) has a Forward Dividend Yield % of 0.39% as of Jul. 15, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Ttbio and its competitors. According to the industry distribution chart, Ttbio ranks #288 out of 314 companies in the Medical Devices & Instruments industry, placing it in the top 91.7%.
Is Ttbio's Forward Dividend Yield % too high?
Ttbio's current Forward Dividend Yield % is 0.39%. The Medical Devices & Instruments industry median Forward Dividend Yield % is 2.09. Ttbio's value of 0.39% is 81.3% below this industry median. Based on the distribution chart, Ttbio ranks #288 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Ttbio has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ttbio's Forward Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ttbio ranks #288 out of 314 companies for Forward Dividend Yield %. This places Ttbio in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. Ttbio's value of 0.39% is 81.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ttbio's current Forward Dividend Yield % of 0.39% is 81.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Ttbio and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ttbio's current Forward Dividend Yield % is 0.39%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ttbio stock overvalued right now?
Based on GuruFocus' analysis, Ttbio (ROCO:6493) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$19.62, compared to a current price of NT$48.85 — trading 149% above its estimated fair value. The current Forward Dividend Yield % is 0.39% and 81.3% below the Medical Devices & Instruments industry median of 2.09. Ttbio's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Ttbio (ROCO:6493), the current Forward Dividend Yield % is 0.39% as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ttbio (ROCO:6493) Overvalued in 2026?
Based on GuruFocus' analysis, Ttbio stock appears to be overvalued.
The current stock price of NT$48.85 is trading 149% above its estimated GF Value™ of NT$19.62.
GuruFocus considers Ttbio to be Significantly Overvalued.
Key valuation signals for ROCO:6493:
Forward Dividend Yield %: 0.39%
GF Value™: NT$19.62 vs. price of NT$48.85 (149% above fair value)
Industry Position: 81.3% below the Medical Devices & Instruments median (#288 of 314)
No single metric tells the full story. See the ROCO:6493 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ttbio Corp is a Taiwan based company engaged in the manufacturing of dental products and accessories. Its products include High-Speed Handpiece Series, Low-Speed Handpiece Series, Dental Spare Parts, Service Rotor, and Maintenance Unit among others.
60GF Score
Get the complete analysis for ROCO:6493
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6493 has been successfully added to your 
